34 results
DEFA14A
EX-3.1
FWBI
First Wave BioPharma Inc
14 Mar 24
Additional proxy soliciting materials
6:10am
8-K
EX-3.1
FWBI
First Wave BioPharma Inc
14 Mar 24
Latiglutenase is a potentially first-in-class oral biotherapeutic for the treatment of celiac disease
6:09am
8-K
EX-3.1
FWBI
First Wave BioPharma Inc
14 Dec 23
First Wave BioPharma Announces 1-for-20 Reverse Stock Split and Results of the Special Meeting of Stockholders
9:15am
10-K
2022 FY
EX-3.1
FWBI
First Wave BioPharma Inc
Annual report
20 Mar 23
4:10pm
8-K
EX-3.1
FWBI
First Wave BioPharma Inc
17 Jan 23
First Wave BioPharma Announces Results of Special Meeting of Stockholders
9:15am
8-A12G
EX-3.1
3a5 ojeplvmoxg
28 Nov 22
Registration of securities
4:18pm
8-K
EX-3.1
0jdqsok6i xe5
25 Aug 22
First Wave BioPharma, Inc. Announces Reverse Stock Split
4:32pm
8-K
EX-3.2
7thuy 8hi
18 Jul 22
First Wave BioPharma, Inc. Announces Private Placement
5:00pm
8-K
EX-3.1
ajphei04
18 Jul 22
First Wave BioPharma, Inc. Announces Private Placement
5:00pm
8-K
EX-3.1
zu2659dpyp qn
7 Jul 22
Amendments to Articles of Incorporation or Bylaws
5:00pm
8-K
EX-3.1
tfeal2ug7tcy 5l65wzv
17 Jun 22
Departure of Directors or Certain Officers
5:01pm
8-K
EX-3.2
dqqbrxe4 5w66kb3u
17 Jun 22
Departure of Directors or Certain Officers
5:01pm
8-K
EX-3.1
d7gfc33
14 Jan 22
Amendments to Articles of Incorporation or Bylaws
5:00pm